Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and ...

Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes. Your diagnosis of an early-stage (Stage 1) gynecologic ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...

After a month off the air, the veteran journalist disclosed that the disease had returned in what doctors described as a ...

DURHAM (WTVD) -- Saturday morning, a large group of people took part in the Gail Parkins Memorial Ovarian Cancer Walk and 5K. ABC11 is partnering with organizers to spread awareness about ovarian ...

After managing two bouts of ovarian cancer, CNN's Christiane Amanpour reveals that she has it for a third time. 'I decided to ...

Researchers assessed variations in patterns of care and time to initial treatment for women diagnosed with breast, cervical, or ovarian cancer in various countries.

R-DXd showed a 50.5% objective response rate in platinum-resistant ovarian cancer, with a 5.6 mg/kg dose deemed optimal for further study. The safety profile was manageable, with 93.5% experiencing ...

The myths and misconceptions attached to ovarian cancer often lead to misdiagnosis and confusion. In an interview with HT Lifestyle, Dr Pushpinder Gulia, director, surgical oncology and robotic ...

BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...

Merck and Eisai announced termination of a phase III trial of pembrolizumab plus lenvatinib (Lenvima) and transarterial chemoembolization (TACE) for unresectable liver cancer after an interim analysis ...